AI
Schedule 13D filing
ASP Isotopes Inc. disclosed a 15.1% stake in ENDRA Life Sciences Inc. (NDRA)
ASP Isotopes Inc. reported owning 15.1% of ENDRA Life Sciences Inc. (NDRA) (254,015 shares) in a Schedule 13D filed Oct 8, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Oct 8, 2026
- Source
- Schedule 13D
From a public Schedule 13D, linked above. Not investment advice, and not a recommendation to buy or sell.